Alnylam Pharmaceuticals (ALNY)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 842 |
| % of all portfolios: | 0.005% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
273 |
$42,409,954 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Dodge & Cox Funds |
0.42 |
Reduce 15.37% |
1,964,415 |
781,150,000 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 12 May 2025 |
REITAN COLLEEN F |
Director |
17 Oct 2024 |
4 |
302.67 |
1,211 |
| 12 May 2025 |
REITAN COLLEEN F |
Director |
29 Aug 2024 |
32 |
286.00 |
9,152 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock